tiprankstipranks
Advertisement

CVAR - ETF AI Analysis

Compare

Top Page

CVAR

Cultivar ETF (CVAR)

Rating:57Neutral
Price Target:
CVAR’s rating suggests it is a middling-quality ETF with a mix of solid, stable companies and a few more challenged names. Strong holdings like Newmont Mining and Hershey support the fund with robust profitability, positive technical trends, and solid growth foundations, while companies such as Alexandria Real Estate, which faces weak financial performance and bearish trading signals, and Albemarle, which has profitability and cash flow issues despite short-term momentum, weigh on the overall assessment. The main risk factor is the presence of several holdings with financial or valuation concerns that could add volatility and limit the fund’s upside.
Positive Factors
Broad Sector Diversification
The ETF spreads its investments across many different sectors, which can help reduce the impact if any one industry struggles.
Multiple Strong Top Holdings
Several of the largest positions, such as Albemarle, Proto Labs, Newmont Mining, and Northwest Gas, have shown strong year-to-date performance that supports the fund’s overall results.
Positive Year-to-Date Performance
The fund has delivered a modest gain so far this year, showing it has held up reasonably well despite some recent short-term weakness.
Negative Factors
High Expense Ratio
The fund’s expense ratio is relatively high for an ETF, which means more of the returns are eaten up by fees over time.
Heavy U.S. Concentration
With the vast majority of its holdings in U.S. companies, the ETF offers limited geographic diversification and is heavily tied to the U.S. market.
Mixed Performance Among Top Holdings
Some key positions, including MarketAxess, Alexandria Equities, and Southwest Airlines, have shown weak year-to-date performance, which can drag on the fund’s returns.

CVAR vs. SPDR S&P 500 ETF (SPY)

CVAR Summary

The Cultivar ETF (CVAR) is an actively managed fund that looks across the total U.S. stock market for companies that appear cheap compared with their business strength, following a value-investing theme rather than a specific index. It holds a mix of large, mid, and small companies in many sectors, including health care, consumer goods, and technology. Well-known names in the fund include The Hershey Company and Southwest Airlines. Someone might invest in CVAR to seek long-term growth while diversifying across many industries, but its value-focused stocks can go up and down with the market and may lag popular growth stocks for long periods.
How much will it cost me?The Cultivar ETF (CVAR) has an expense ratio of 0.87%, which means you’ll pay $8.70 per year for every $1,000 invested. This expense ratio is higher than average because the fund is actively managed, focusing on identifying undervalued companies with strong fundamentals rather than simply tracking an index.
What would affect this ETF?The Cultivar ETF (CVAR) could benefit from a recovery in the U.S. economy, as value investing strategies often perform well during periods of market stability and growth. Positive trends in sectors like Health Care and Technology, which make up significant portions of the ETF, could also drive returns. However, rising interest rates or economic uncertainty might negatively impact some of its top holdings, such as real estate and energy companies, and broader market volatility could challenge its value-focused approach.

CVAR Top 10 Holdings

CVAR’s story is about selective U.S. value bets rather than big, flashy growth names. On the positive side, Albemarle and Proto Labs have been rising, giving the fund a lift from materials and niche industrial tech, while Northwest Gas and Healthcare Services add a steadier, defensive backbone from utilities and health care. Offsetting that strength, MarketAxess has been lagging and Alexandria Equities has been a noticeable drag, showing the risks in financials and real estate. Overall, the ETF is diversified but leans into health care, consumer defensives, and materials within the U.S. market.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Marketaxess Holdings4.32%$1.68M$5.80B-26.76%
68
Neutral
Core Laboratories3.21%$1.25M$803.54M53.01%
72
Outperform
Healthcare Services2.55%$989.72K$1.55B57.36%
72
Outperform
Albemarle2.05%$797.32K$22.19B240.78%
58
Neutral
Alexandria Equities1.94%$752.38K$8.21B-40.82%
47
Neutral
Proto Labs1.88%$731.03K$1.54B80.25%
70
Outperform
Newmont Mining1.82%$706.35K$128.85B114.68%
81
Outperform
Northwest Gas1.76%$681.84K$2.22B22.42%
73
Outperform
Southwest Airlines1.70%$659.56K$19.28B43.34%
66
Neutral
The Hershey Company1.62%$628.10K$38.81B14.37%
76
Outperform

CVAR Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
29.00
Negative
100DMA
28.98
Negative
200DMA
28.07
Positive
Market Momentum
MACD
0.09
Negative
RSI
53.23
Neutral
STOCH
48.58
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For CVAR, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 28.70, equal to the 50-day MA of 29.00, and equal to the 200-day MA of 28.07, indicating a neutral trend. The MACD of 0.09 indicates Negative momentum. The RSI at 53.23 is Neutral, neither overbought nor oversold. The STOCH value of 48.58 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CVAR.

CVAR Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$39.05M0.87%
57
Neutral
$99.90M0.91%
74
Outperform
$84.28M0.50%
73
Outperform
$73.98M0.75%
68
Neutral
$59.01M0.30%
67
Neutral
$39.24M0.45%
73
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CVAR
Cultivar ETF
28.71
3.83
15.39%
BAMV
Brookstone Value Stock ETF
GMOV
GMO US Value ETF
SASS
M.D. Sass Concentrated Value ETF
VUSV
Vanguard Wellington U.S. Value Active ETF
GVLE
Goldman Sachs Value Opportunities ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement